Global Companion Diagnostics Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Companion Diagnostics Revenue
• 1.4 Market by Type
  • 1.4.1 Global Companion Diagnostics Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Polymerase Chain Reaction (PCR)
  • 1.4.3 Immunohistochemistry (IHC)
  • 1.4.4 In Situ Hybridization (ISH)
  • 1.4.5 Next Generation Sequencing (NGS)
• 1.5 Market by Application
  • 1.5.1 Global Companion Diagnostics Market Share by Application: 2020 VS 2026
  • 1.5.2 Hospitals
  • 1.5.3 Pharmaceutical Companies
  • 1.5.4 Laboratories
  • 1.5.5 Other
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Companion Diagnostics Market Perspective (2015-2026)
• 2.2 Global Companion Diagnostics Growth Trends by Regions
  • 2.2.1 Companion Diagnostics Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Companion Diagnostics Historic Market Share by Regions (2015-2020)
  • 2.2.3 Companion Diagnostics Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Companion Diagnostics Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Companion Diagnostics Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Companion Diagnostics Players by Market Size
  • 3.1.1 Global Top Companion Diagnostics Players by Revenue (2015-2020)
  • 3.1.2 Global Companion Diagnostics Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Companion Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Companion Diagnostics Market Concentration Ratio
  • 3.2.1 Global Companion Diagnostics Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Companion Diagnostics Revenue in 2019
• 3.3 Companion Diagnostics Key Players Head office and Area Served
• 3.4 Key Players Companion Diagnostics Product Solution and Service
• 3.5 Date of Enter into Companion Diagnostics Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Companion Diagnostics Historic Market Size by Type (2015-2020)
• 4.2 Global Companion Diagnostics Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Companion Diagnostics Market Size by Application (2015-2020)
• 5.2 Global Companion Diagnostics Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Companion Diagnostics Market Size (2015-2020)
• 6.2 Companion Diagnostics Key Players in North America (2019-2020)
• 6.3 North America Companion Diagnostics Market Size by Type (2015-2020)
• 6.4 North America Companion Diagnostics Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Companion Diagnostics Market Size (2015-2020)
• 7.2 Companion Diagnostics Key Players in Europe (2019-2020)
• 7.3 Europe Companion Diagnostics Market Size by Type (2015-2020)
• 7.4 Europe Companion Diagnostics Market Size by Application (2015-2020)

8 China

• 8.1 China Companion Diagnostics Market Size (2015-2020)
• 8.2 Companion Diagnostics Key Players in China (2019-2020)
• 8.3 China Companion Diagnostics Market Size by Type (2015-2020)
• 8.4 China Companion Diagnostics Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Companion Diagnostics Market Size (2015-2020)
• 9.2 Companion Diagnostics Key Players in Japan (2019-2020)
• 9.3 Japan Companion Diagnostics Market Size by Type (2015-2020)
• 9.4 Japan Companion Diagnostics Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Companion Diagnostics Market Size (2015-2020)
• 10.2 Companion Diagnostics Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Companion Diagnostics Market Size by Type (2015-2020)
• 10.4 Southeast Asia Companion Diagnostics Market Size by Application (2015-2020)

11 India

• 11.1 India Companion Diagnostics Market Size (2015-2020)
• 11.2 Companion Diagnostics Key Players in India (2019-2020)
• 11.3 India Companion Diagnostics Market Size by Type (2015-2020)
• 11.4 India Companion Diagnostics Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Companion Diagnostics Market Size (2015-2020)
• 12.2 Companion Diagnostics Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Companion Diagnostics Market Size by Type (2015-2020)
• 12.4 Central & South America Companion Diagnostics Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Roche Holdings
  • 13.1.1 Roche Holdings Company Details
  • 13.1.2 Roche Holdings Business Overview
  • 13.1.3 Roche Holdings Companion Diagnostics Introduction
  • 13.1.4 Roche Holdings Revenue in Companion Diagnostics Business (2015-2020))
  • 13.1.5 Roche Holdings Recent Development
• 13.2 Abbott Laboratories
  • 13.2.1 Abbott Laboratories Company Details
  • 13.2.2 Abbott Laboratories Business Overview
  • 13.2.3 Abbott Laboratories Companion Diagnostics Introduction
  • 13.2.4 Abbott Laboratories Revenue in Companion Diagnostics Business (2015-2020)
  • 13.2.5 Abbott Laboratories Recent Development
• 13.3 Thermo Fisher Scientific
  • 13.3.1 Thermo Fisher Scientific Company Details
  • 13.3.2 Thermo Fisher Scientific Business Overview
  • 13.3.3 Thermo Fisher Scientific Companion Diagnostics Introduction
  • 13.3.4 Thermo Fisher Scientific Revenue in Companion Diagnostics Business (2015-2020)
  • 13.3.5 Thermo Fisher Scientific Recent Development
• 13.4 Agilent Technologies
  • 13.4.1 Agilent Technologies Company Details
  • 13.4.2 Agilent Technologies Business Overview
  • 13.4.3 Agilent Technologies Companion Diagnostics Introduction
  • 13.4.4 Agilent Technologies Revenue in Companion Diagnostics Business (2015-2020)
  • 13.4.5 Agilent Technologies Recent Development
• 13.5 Life Technologies
  • 13.5.1 Life Technologies Company Details
  • 13.5.2 Life Technologies Business Overview
  • 13.5.3 Life Technologies Companion Diagnostics Introduction
  • 13.5.4 Life Technologies Revenue in Companion Diagnostics Business (2015-2020)
  • 13.5.5 Life Technologies Recent Development
• 13.6 GE Healthcare
  • 13.6.1 GE Healthcare Company Details
  • 13.6.2 GE Healthcare Business Overview
  • 13.6.3 GE Healthcare Companion Diagnostics Introduction
  • 13.6.4 GE Healthcare Revenue in Companion Diagnostics Business (2015-2020)
  • 13.6.5 GE Healthcare Recent Development
• 13.7 Agendia
  • 13.7.1 Agendia Company Details
  • 13.7.2 Agendia Business Overview
  • 13.7.3 Agendia Companion Diagnostics Introduction
  • 13.7.4 Agendia Revenue in Companion Diagnostics Business (2015-2020)
  • 13.7.5 Agendia Recent Development
• 13.8 Qiagen
  • 13.8.1 Qiagen Company Details
  • 13.8.2 Qiagen Business Overview
  • 13.8.3 Qiagen Companion Diagnostics Introduction
  • 13.8.4 Qiagen Revenue in Companion Diagnostics Business (2015-2020)
  • 13.8.5 Qiagen Recent Development
• 13.9 Genomic Health
  • 13.9.1 Genomic Health Company Details
  • 13.9.2 Genomic Health Business Overview
  • 13.9.3 Genomic Health Companion Diagnostics Introduction
  • 13.9.4 Genomic Health Revenue in Companion Diagnostics Business (2015-2020)
  • 13.9.5 Genomic Health Recent Development
• 13.10 Myriad Genetics
  • 13.10.1 Myriad Genetics Company Details
  • 13.10.2 Myriad Genetics Business Overview
  • 13.10.3 Myriad Genetics Companion Diagnostics Introduction
  • 13.10.4 Myriad Genetics Revenue in Companion Diagnostics Business (2015-2020)
  • 13.10.5 Myriad Genetics Recent Development
• 13.11 Advanced Cell Diagnostics
  • 10.11.1 Advanced Cell Diagnostics Company Details
  • 10.11.2 Advanced Cell Diagnostics Business Overview
  • 10.11.3 Advanced Cell Diagnostics Companion Diagnostics Introduction
  • 10.11.4 Advanced Cell Diagnostics Revenue in Companion Diagnostics Business (2015-2020)
  • 10.11.5 Advanced Cell Diagnostics Recent Development
• 13.12 Danaher
  • 10.12.1 Danaher Company Details
  • 10.12.2 Danaher Business Overview
  • 10.12.3 Danaher Companion Diagnostics Introduction
  • 10.12.4 Danaher Revenue in Companion Diagnostics Business (2015-2020)
  • 10.12.5 Danaher Recent Development
• 13.13 Applied Proteomics
  • 10.13.1 Applied Proteomics Company Details
  • 10.13.2 Applied Proteomics Business Overview
  • 10.13.3 Applied Proteomics Companion Diagnostics Introduction
  • 10.13.4 Applied Proteomics Revenue in Companion Diagnostics Business (2015-2020)
  • 10.13.5 Applied Proteomics Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer